Sandia National Laboratories has published an article on the longstanding and productive collaboration between Sandia’s Center for Integrated Nanotechnologies (CINT) and Imagion Biosystems’ R&D scientists.
Highlights of the collaboration cited in the article include Sandia scientists’ contributions to nanoparticle size and shape analysis, the co-development of a new process for high-yield, precise-size nanoparticle production, and the successful transfer of the process to Imagion Biosystems’ clinical-trials nanoparticles manufacturing partner, ChemConnection.
Read Magnetic nanoparticles leap from lab bench to breast cancer clinical trials at Sandia National Laboratories.
Executive Chairman Bob Proulx on Pitt Street Research’s Stocks Down Under Podcast: Getting ready for a Phase 2 Study
August 21, 2025
Earlier this month, our own Bob Proulx, Executive Chairman of Imagion Biosystems, had the opportunity to join Stuart Roberts on Pitt Street Research’s podcast Stocks